Details for New Drug Application (NDA): 210231
✉ Email this page to a colleague
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 210231
Tradename: | SUCCINYLCHOLINE CHLORIDE |
Applicant: | Amring Pharms |
Ingredient: | succinylcholine chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 210231
Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 210231
Suppliers and Packaging for NDA: 210231
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 210231 | ANDA | Amring Pharmaceuticals Inc. | 69918-700 | 69918-700-11 | 10 VIAL, MULTI-DOSE in 1 CARTON (69918-700-11) / 10 mL in 1 VIAL, MULTI-DOSE (69918-700-04) |
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 210231 | ANDA | Amring Pharmaceuticals Inc. | 69918-700 | 69918-700-28 | 25 VIAL, MULTI-DOSE in 1 CARTON (69918-700-28) / 10 mL in 1 VIAL, MULTI-DOSE (69918-700-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Jun 4, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription